Frequency and Type of Red Flags in Patients With Covid-19 and Headache: A Series of 104 Hospitalized Patients

被引:30
作者
Garcia-Azorin, David [1 ,2 ]
Trigo, Javier [1 ]
Talavera, Blanca [1 ]
Martinez-Pias, Enrique [1 ]
Sierra, Alvaro [1 ]
Porta-Etessam, Jesus [3 ,4 ]
Arenillas, Juan F. [1 ,5 ,6 ]
Guerrero, Angel L. [1 ,2 ,6 ]
机构
[1] Hosp Clin Univ Valladolid, Dept Neurol, Headache Unit, Ave Ramon y Cajal 3, Valladolid 47005, Spain
[2] Inst Biomed Res Salamanca IBSAL, Salamanca, Spain
[3] Hosp Clin San Carlos, IdISSC, Inst Neurosci, Headache Unit,Dept Neurol, Madrid, Spain
[4] Univ Complutense Madrid, Dept Med, Madrid, Spain
[5] Univ Valladolid, CSIC, Inst Biol & Genet Mol, Neurovasc Res Lab, Madrid, Spain
[6] Univ Valladolid, Sch Med, Dept Med, Valladolid, Spain
来源
HEADACHE | 2020年 / 60卷 / 08期
关键词
Covid-19; neurology; headache; coronavirus; diagnosis; EMERGENCY-DEPARTMENT; MANAGEMENT; MIGRAINE;
D O I
10.1111/head.13927
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective In this study, we aimed to evaluate the frequency of the main red flags in patients with headache who do have Covid-19. Background Headache is one of the most frequent neurologic symptoms of Coronavirus disease 2019 (Covid-19). Diagnosis of secondary headache disorders is still based on the presence of red flags. Design and Methods Cross-sectional study of hospitalized patients with confirmed Covid-19 disease. We interrogated every patient about the presence of headache and if so, a headache expert conducted a structured interview assessing the presence and type of the main red flags. We evaluated the presence of laboratory abnormalities on admission. Results We screened 576 consecutive patients, 130/576 (22.6%) described headache, and 104 were included in the study. Mean age of patients was 56.7 (standard deviation: 11.2) and 66/104 (63.4%) were female. Red flags concerning prior medical history were present in 79/104 (76.0%) cases, and those related to the headache itself were observed in 99/104 (95.2%) patients. All patients 104/104 (100%) described systemic symptoms and 86/104 (82.7%) some neurologic symptoms. Laboratory results were abnormal in 98/104 (94.2%) cases. The most frequent red flags were fever, in 93/104 (89.4%) patients, cough, in 89/104 (85.6% cases), and increased C-reactive protein in 84/100 (84.0%) cases. Conclusion In patients with Covid-19 that described the headache red flags were present in most cases. There was not any universal red flag, being necessary the comprehensive evaluation of all of them.
引用
收藏
页码:1664 / 1672
页数:9
相关论文
共 31 条
[11]  
Godwin SA, 2019, ANN EMERG MED, V74, pE41, DOI 10.1016/j.annemergmed.2019.07.009
[12]   Clinical Characteristics of Coronavirus Disease 2019 in China [J].
Guan, W. ;
Ni, Z. ;
Hu, Yu ;
Liang, W. ;
Ou, C. ;
He, J. ;
Liu, L. ;
Shan, H. ;
Lei, C. ;
Hui, D. S. C. ;
Du, B. ;
Li, L. ;
Zeng, G. ;
Yuen, K. -Y. ;
Chen, R. ;
Tang, C. ;
Wang, T. ;
Chen, P. ;
Xiang, J. ;
Li, S. ;
Wang, Jin-lin ;
Liang, Z. ;
Peng, Y. ;
Wei, L. ;
Liu, Y. ;
Hu, Ya-hua ;
Peng, P. ;
Wang, Jian-ming ;
Liu, J. ;
Chen, Z. ;
Li, G. ;
Zheng, Z. ;
Qiu, S. ;
Luo, J. ;
Ye, C. ;
Zhu, S. ;
Zhong, N. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (18) :1708-1720
[13]   COVID-19 is catalyzing the adoption of teleneurology [J].
Klein, Brad C. ;
Busis, Neil A. .
NEUROLOGY, 2020, 94 (21) :903-904
[14]   Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study [J].
Lechien, Jerome R. ;
Chiesa-Estomba, Carlos M. ;
De Siati, Daniele R. ;
Horoi, Mihaela ;
Le Bon, Serge D. ;
Rodriguez, Alexandra ;
Dequanter, Didier ;
Blecic, Serge ;
El Afia, Fahd ;
Distinguin, Lea ;
Chekkoury-Idrissi, Younes ;
Hans, Stephane ;
Lopez Delgado, Irene ;
Calvo-Henriquez, Christian ;
Lavigne, Philippe ;
Falanga, Chiara ;
Barillari, Maria Rosaria ;
Cammaroto, Giovanni ;
Khalife, Mohamad ;
Leich, Pierre ;
Souchay, Christel ;
Rossi, Camelia ;
Journe, Fabrice ;
Hsieh, Julien ;
Edjlali, Myriam ;
Carlier, Robert ;
Ris, Laurence ;
Lovato, Andrea ;
De Filippis, Cosimo ;
Coppee, Frederique ;
Fakhry, Nicolas ;
Ayad, Tareck ;
Saussez, Sven .
EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2020, 277 (08) :2251-2261
[15]  
Lippi G, 2020, CLIN CHEM LAB MED, V58, P1131, DOI [10.1515/cclm-2020-1761, 10.1515/cclm-2020-0198]
[16]   Headache medication and the COVID-19 pandemic [J].
MaassenVanDenBrink, Antoinette ;
de Vries, Tessa ;
Danser, A. H. Jan .
JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01)
[17]   Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China [J].
Mao, Ling ;
Jin, Huijuan ;
Wang, Mengdie ;
Hu, Yu ;
Chen, Shengcai ;
He, Quanwei ;
Chang, Jiang ;
Hong, Candong ;
Zhou, Yifan ;
Wang, David ;
Miao, Xiaoping ;
Li, Yanan ;
Hu, Bo .
JAMA NEUROLOGY, 2020, 77 (06) :683-690
[18]   Diagnosis and Treatment of Adults with Community-acquired Pneumonia An Official Clinical Practice Guideline of the American Thoracic Society and Infectious Diseases Society of America [J].
Metlay, Joshua P. ;
Waterer, Grant W. ;
Long, Ann C. ;
Anzueto, Antonio ;
Brozek, Jan ;
Crothers, Kristina ;
Cooley, Laura A. ;
Dean, Nathan C. ;
Fine, Michael J. ;
Flanders, Scott A. ;
Griffin, Marie R. ;
Metersky, Mark L. ;
Musher, Daniel M. ;
Restrepo, Marcos, I ;
Whitney, Cynthia G. .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2019, 200 (07) :E45-E67
[19]  
Ministry of Health, TECHNICAL DOCUMENTS
[20]  
National Epidemiologic Surveillance Network, 2020, 31 NAT EP SURV NETW